Search for: "PFIZER INC, A corporation" Results 221 - 240 of 338
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Apr 2022, 5:25 am by Matrix Legal Support Service
The following Supreme Court judgments remain outstanding: (As of 27/4/22) The Law Debenture Trust Corporation plc v Ukraine (Represented by the Minister of Finance of Ukraine acting upon the instructions of the Cabinet of Ministers of Ukraine) Nos. 2 and 3, heard 9-12 December 2019 BTI 2014 LLC v Sequana SA and Ors, heard 4 May 2021 East of England Ambulance Service NHS Trust v Flowers and Ors, heard 22 June 2021 Basfar v Wong, heard 13th-14th October Secretary of State for the Home… [read post]
3 Aug 2011, 5:11 am by Lawrence B. Ebert
Just north of Merck's Rahway site on US 1 is the now abandoned site of Exxon's Corporate Research Laboratory. 24/7WallSt , comparing Merck and Pfizer, discussed the patent issue: Differences between the two companies is most evident in the strategic measures the big pharma players seem to be taking to meet challenges arising from the expiration of key patents and the rise of generic competition.(...) [read post]
18 Jan 2007, 6:23 am
Most innovative use of technology in a law dept: John Theriault, vice president, and Mary Ann Sarao, director, global security of Pfizer Inc. [read post]
28 Mar 2022, 3:43 am by Jocelyn Hutton
The following Supreme Court judgments remain outstanding: (As of 28/3/22) The Law Debenture Trust Corporation plc v Ukraine (Represented by the Minister of Finance of Ukraine acting upon the instructions of the Cabinet of Ministers of Ukraine) Nos. 2 and 3, heard 9-12 December 2019 BTI 2014 LLC v Sequana SA and Ors, heard 4 May 2021 East of England Ambulance Service NHS Trust v Flowers and Ors, heard 22 June 2021 Basfar v Wong, heard 13th-14th October Secretary of State for the… [read post]
16 May 2022, 3:01 am by Jocelyn Hutton
The following Supreme Court judgments remain outstanding: (As of 18/5/22) The Law Debenture Trust Corporation plc v Ukraine (Represented by the Minister of Finance of Ukraine acting upon the instructions of the Cabinet of Ministers of Ukraine) Nos. 2 and 3, heard 9-12 December 2019 BTI 2014 LLC v Sequana SA and Ors, heard 4 May 2021 East of England Ambulance Service NHS Trust v Flowers and Ors, heard 22 June 2021 Basfar v Wong, heard 13th-14th October Secretary of State for the Home… [read post]
6 Feb 2009, 8:19 am
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition Petitioner's reply Brief amicus curiae of the Washington Legal Foundation (in support of petitioner) Brief amicus curiae of Pfizer, Inc. [read post]
29 May 2015, 8:25 am
The NLDC produced a development plan that would revitalize Fort Trumbull by building housing, office space, and other facilities that would support a new headquarters that Pfizer, Inc. [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
In the case of Xalatan®, In January 2004, the Essential Inventions, Inc. [read post]
28 Dec 2023, 12:56 pm by David W.S. Lieberman
In 2018, Pfizer agreed to pay $24 million and enter a corporate integrity agreement to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking three Pfizer drugs, in violation of the False Claims Act. [read post]
17 Jun 2012, 3:52 pm by Stephen Jenei
Prior to founding RaymondStevenson in 2007, Betsy worked with Pfizer Inc’s Corporate Communications group, where she developed strategy and directed international and top-tier media relations for the company’s Oncology and Central Nervous System portfolios and served as media counsel for Pfizer’s Chief Medical Officer and Senior Vice President Worldwide Development. [read post]
11 Nov 2009, 10:23 am
Now, four years after that decision gave Susette Kelo's land to private developers for a project including a hotel and offices intended to enhance Pfizer Inc.'s nearby corporate facility, the pharmaceutical giant has announced it will close its research and development headquarters in New London, Connecticut. [read post]
19 Oct 2006, 7:29 pm
Guidelines are meant to reflect independent medical opinion but too much corporate influence could lead to corporations trying to guide health care in ways that benefit them directly. [read post]
12 May 2015, 3:26 pm by James Galvin
The following is a list of some of the UBS Reverse Convertible Notes offered: CUSIP Issuer Product Name 90261J426 UBS Yield Optimization Notes with Contingent Protection linked to Starbucks Corp. 90261J434 UBS Yield Optimization Notes with Contingent Protection linked to Intel Corp. 90261J459 UBS Yield Optimization Notes with Contingent Protection linked to Apple, Inc. 90261J319 UBS Yield Optimization Notes with Contingent Protection linked linked to Occidental Petroleum Corp.… [read post]